Welcome to LookChem.com Sign In|Join Free
  • or

Encyclopedia

Aldoxorubicin

Base Information
  • Chemical Name:Aldoxorubicin
  • CAS No.:1361644-26-9
  • Molecular Formula:C37H42N4O13
  • Molecular Weight:750.75
  • Hs Code.:
  • European Community (EC) Number:813-952-4
  • UNII:C28MV4IM0B
  • DSSTox Substance ID:DTXSID001098062
  • Nikkaji Number:J2.017.217G
  • Wikipedia:Aldoxorubicin
  • NCI Thesaurus Code:C68921
  • Metabolomics Workbench ID:149612
  • ChEMBL ID:CHEMBL2107818
  • Mol file:1361644-26-9.mol
Aldoxorubicin

Synonyms:Aldoxo;aldoxorubicin;DOXO-EMCH;INNO-206

Suppliers and Price of Aldoxorubicin
Supply Marketing:
Business phase:
The product has achieved commercial mass production*data from LookChem market partment
Manufacturers and distributors:
  • Manufacture/Brand
  • Chemicals and raw materials
  • Packaging
  • price
  • Crysdot
  • INNO-206 98+%
  • 10mg
  • $ 121.00
  • Crysdot
  • INNO-206 98+%
  • 5mg
  • $ 94.00
  • Crysdot
  • INNO-206 98+%
  • 100mg
  • $ 605.00
  • Crysdot
  • INNO-206 98+%
  • 50mg
  • $ 413.00
  • ChemScene
  • Aldoxorubicin 95.99%
  • 50mg
  • $ 695.00
  • ChemScene
  • Aldoxorubicin 95.99%
  • 10mg
  • $ 174.00
  • ChemScene
  • Aldoxorubicin 95.99%
  • 5mg
  • $ 135.00
  • ChemScene
  • Aldoxorubicin 95.99%
  • 100mg
  • $ 1180.00
  • Ambeed
  • Inno-206 98+%
  • 100mg
  • $ 1143.00
Total 12 raw suppliers
Chemical Property of Aldoxorubicin
Chemical Property:
  • PKA:7.36±0.60(Predicted) 
  • PSA:271.33000 
  • Density:1.60±0.1 g/cm3(Predicted) 
  • LogP:1.86830 
  • XLogP3:1.3
  • Hydrogen Bond Donor Count:7
  • Hydrogen Bond Acceptor Count:15
  • Rotatable Bond Count:12
  • Exact Mass:750.27483741
  • Heavy Atom Count:54
  • Complexity:1510
Purity/Quality:

97% *data from raw suppliers

INNO-206 98+% *data from reagent suppliers

Safty Information:
  • Pictogram(s):  
  • Hazard Codes: 
MSDS Files:

SDS file from LookChem

Useful:
  • Canonical SMILES:CC1C(C(CC(O1)OC2CC(CC3=C2C(=C4C(=C3O)C(=O)C5=C(C4=O)C(=CC=C5)OC)O)(C(=NNC(=O)CCCCCN6C(=O)C=CC6=O)CO)O)N)O
  • Isomeric SMILES:C[C@H]1[C@H]([C@H](C[C@@H](O1)O[C@H]2C[C@@](CC3=C2C(=C4C(=C3O)C(=O)C5=C(C4=O)C(=CC=C5)OC)O)(/C(=N/NC(=O)CCCCCN6C(=O)C=CC6=O)/CO)O)N)O
  • Recent ClinicalTrials:QUILT-2.024: Phase 2 Neoadjuvant, Consolidation, and Adjuvant Combination NANT Immunotherapy Versus Standard of Care in Subjects With Resectable Non-small Cell Lung Cancer
  • Recent EU Clinical Trials:A Multicenter, Randomized, Open-Label Phase 2b Study to Investigate the Efficacy and Safety of Aldoxorubicin Compared to Topotecan in Subjects with Metastatic Small Cell Lung Cancer Who Either Relapsed or Were Refractory to Prior Chemotherapy
Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 1361644-26-9